Form 4: Jaguar Health CEO Lisa Conte Reports Acquisition of Stock Options and Restricted Stock Units
SEC Form 4 Filing
Lisa Conte, CEO of Jaguar Health, reports acquiring stock options and restricted stock units on October 8, 2024, under the company's 2014 Stock Incentive Plan.
Summary
- Lisa Conte, the CEO and President of Jaguar Health, filed a Form 4 on October 10, 2024, reporting changes in beneficial ownership.
- On October 8, 2024, Conte acquired 16,503 restricted stock units and 132,020 stock options at a price of $0.
- The restricted stock units vest in three equal annual installments starting October 8, 2025.
- The stock options vest ratably on a monthly basis over 36 months from the grant date, contingent upon continued employment.
- The stock options have an exercise price of $1.29 and expire on October 8, 2034.
- Following the reported transactions, Conte beneficially owns 16,624 shares of common stock and 132,020 stock options.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The grant of stock options and restricted stock units to the CEO is a common practice to align management's interests with shareholders, which is generally viewed favorably. There are no indications of negative news or concerns.
Positives
- The acquisition of stock options and restricted stock units by the CEO aligns her interests with those of the shareholders.
- The vesting schedules for the restricted stock units and stock options incentivize long-term performance and continued employment.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedules of the granted securities.
Industry Context
This type of filing is standard for publicly traded companies and reflects executive compensation practices.
Stakeholder Impact
- The grants incentivize the CEO to improve company performance, potentially benefiting shareholders.
- Employees may view the grants as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| May 23, 2024 | Jaguar Health effected a 60-for-1 reverse stock split. |
| October 8, 2024 | Date of the transaction: acquisition of restricted stock units and stock options. |
| October 8, 2025 | First vesting date for the restricted stock units. |
| October 8, 2034 | Expiration date for the stock options. |
| October 10, 2024 | Date of Form 4 filing. |
Keywords
Form 4, Jaguar Health, Lisa Conte, Stock Options, Restricted Stock Units, Beneficial Ownership, Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.